Mapping your unique genetic pathway across 14 distinct metabolic systems and 49 peptides allows PlexusDx to recommend semaglutide or alternative compounds like tirzepatide based on your post-surgical biology, not assumptions
Falgreen, S
you may need to increase after assessing tolerance Poor quality productonly purchase from verified sources with third-party testing certificates (COAs) Insufficient training stimulusIGF-1 LR3 enhances your body's response to training, but you still need to train hard Inadequate nutritionnot enough protein or calories limits the peptide's ability to build muscle Key Research [1]"Long R3 IGF-I differently affect development and messenger ribonucleic acid abundance for IGF-binding proteins and type I IGF receptors in bovine embryos" Prelle K, Stojkovic M, et al., 2001 Finding: This foundational study demonstrated that LR3 IGF-I has dramatically reduced binding to IGF binding proteins compared to regular IGF-1, explaining why it remains active in the bloodstream much longer and has greater bioavailability for tissue effects
DOI.org (Crossref) , Sports Medicine (Auckland, N.Z.) , vol
Monitor for Side Effects: Side effects are generally minimal, but you might experience mild redness, swelling, or tenderness at the injection site
It was first characterized by Predrag Sikiric and colleagues at the University of Zagreb in the early 1990s, and a 2025 literature and patent review cataloged its effects across gastrointestinal, musculoskeletal, and neural models
